MML Investors Services’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-11,200
Closed -$301K 1981
2021
Q2
$301K Buy
+11,200
New +$328K ﹤0.01% 1619
2021
Q1
Sell
-31,300
Closed -$716K 1824
2020
Q4
$716K Buy
+31,300
New +$721K 0.01% 984
2019
Q4
Sell
-13,800
Closed -$176K 1533
2019
Q3
$176K Buy
+13,800
New +$199K ﹤0.01% 1415

Other funds holding MGNX

MML Investors Services's MGNX Position: Q3 2021 in Review

MML Investors Services sold out of MacroGenics (MGNX) in Q3 2021, closing a stake of 11,200 shares — an estimated $301K sold.

MML Investors Services first reported a position in MGNX in Q3 2019 and held it in 3 quarters. The position peaked at $716K in Q4 2020. 154 funds tracked by Wall St. Rank hold MGNX as of Q3 2021.

  • MML Investors Services reported no remaining MacroGenics position as of Q3 2021 after selling out during the quarter.
  • MML Investors Services sold 11,200 MacroGenics shares in Q3 2021, an estimated $301K.
  • MML Investors Services first reported a position in MacroGenics in Q3 2019 and held it in 3 quarters.
  • MML Investors Services's MacroGenics position peaked at $716K in Q4 2020.
  • 154 funds tracked by Wall St. Rank held MacroGenics as of Q3 2021.

Based on MML Investors Services's 13F filing for Q3 2021, filed 15 Nov 2021.